Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
A new study published in the journal of BMC Oral Health highlighted the role of salivary microbiota and polyamines in ...
(NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update on its subsidiary, Adimune, Inc., (“Adimune”) ...
Their paper is published in Molecular Psychiatry. The mutation increases levels of glycine decarboxylase, or GLDC, an enzyme responsible for regulating glycine in the brain. Glycine activates ...
MOUNTAIN VIEW, Kalifornien - Aditxt, Inc. (NASDAQ: ADTX), ein Biotech-Unternehmen mit einer geringen Marktkapitalisierung von 0,85 Millionen US-Dollar und Fokus auf Gesundheitsinnovationen, meldet For ...
The mutation increases levels of glycine decarboxylase, or GLDC, an enzyme responsible for regulating glycine in the brain. Glycine activates receptors for the neurotransmitter glutamate ...
Once full approval is granted Upstaza (eladocagene exuparvovec) will become the first disease-modifying treatment for AADC (aromatic L-amino acid decarboxylase) deficiency, as well as the first ...
Hosted on MSN27d
Genetic mutation linked to schizophrenia in both humans and miceThe mutation increases levels of glycine decarboxylase, or GLDC, an enzyme responsible for regulating glycine in the brain. Glycine activates receptors for the neurotransmitter glutamate ...
Antigen-specific, vaccine-based approaches using β-cell-specific autoantigens to induce immune tolerance are under development and include glutamate decarboxylase 65 kDa isoform (GAD65 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback